filgrastim-ayow | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

822 results for “filgrastim-ayow”

Trials

View all 675 →

A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy

337 participants · First posted Jan 27, 2011

Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy

34 participants · First posted Mar 6, 2000

Filgrastim for Premature Ovarian Insufficiency

10 participants · First posted May 26, 2016

Drugs

View all 112 →

Filgrastim(Accofil, Granix, Grastofil, Neupogen, Nivestim, Nivestym, Ratiograstim, Releuko, Zarxio, Zarzio, Filgrastim Hexal, Tevagrastim, Zefylti)

Conditions: Congenital neutropenia, Cyclic neutropenia +5 more

Filgrastim ratiopharm

filgrastim + plerixafor

News

View all 35 →

FDA Approves Fylnetra, Fifth Biosimilar of Neulasta, for Febrile Neutropenia

Amneal Submits BLA for Omalizumab Biosimilar to Challenge $4.1 Billion XOLAIR Market

FDA Approves Nypozi (filgrastim-txid) as Biosimilar to Neupogen

Page 1 of 83